1Koglin J, Pehlivanli S, Schwaiblmair M, et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure[J ]. J Am Coll Cardiol,2001,38( 7) : 1934 - 1941.
2Peter A,McCullough MD,Maisel MD,et al. B type natriuretic peptides:A diagnostic breakthough for clinicians [J]. Rev Cardiovasc Med ,2003,4(2) :72 - 80.
4Kunii Y, Kamada M,Ohtsuki S, et al. Plasma brain natriuretic peptidc and the evaluation of volume overload in infants and children with congenital heart disease[J ]. Acta Med Okayama ,2003,57(4): 191-197.
5Koch A, Singer H. Normal value of B type natriuretic peptide in infants,children,and adolescents[J]. Heart ,2003,89(8) :875-878.
6Multinational Study Investigators. Rapid measurement of B- type natriuretic peptide in the emergency diagnosis of heart failure[J ]. N Engl J Med ,2002,347(3) : 161 - 167.
7Yuk ML,Bradley BK, Brian MF, et al. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease[ J ]. Cardiosource, 2005,95(4) :474 - 478.
10Koulouri S, Acherman RJ,Wong PC, et al. Utility of B type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress [ J ]. Pediatr Cardiol,2004,25(4) :341 - 346.
2Troughton RW, Frampton CM, Yandle TG, et al.Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations[J].Lancet,2000,355(9210):1126-1130.
3Hammerer-Lercher A, Puschendorf B, Mair J. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients[J].Clin Lab,2001,47(5-6):265-277.
4Ikemoto Y,Nogi S,Teraguchi M,et al.Early changes in plasma brain and atrial natriuretic peptides in premature infants:correlation with pulmonary arterial pressure[J].Early Hum Dev,1996,46(1,2):55-62.
5Yoshibayashi M, Kamiya T, Saito Y, et al.Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth[J].Eur J Endocrinol,1995,133(2):207-209.
6Yasue H, Yoshimura M, Sumida H, et al.Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure[J].Circulation,1994,90(1):195-203.
8Mueller C, Buser P. B-type natriuretic peptide (BNP):can it improve our management of patients with congestive heart failure[J].Swiss Med Wkly,2002,132(43-44):618-622.
9Murdoch DR,McDonagh TA,Byrne J,et al.Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy[J].Am Heart J,1999,138(6 Pt 1):1126-1132.
10Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment[J].Heart,1996,76 (3):232-237.
